Grifols (GIKLY) Non-Current Assets (2009 - 2025)

Grifols (GIKLY) posted Non-Current Assets of $17.0 billion for Q4 2025, up 1.71% quarter-over-quarter from $16.8 billion in Q4 2024, and up 1.71% year-on-year from $16.8 billion in Q4 2024.

Grifols (GIKLY) Non-Current Assets (2009 - 2025) Analysis & Trends

Grifols (GIKLY) has reported Non-Current Assets for 16 consecutive years, with $17.0 billion the latest figure, recorded in Q4 2025.

  • Non-Current Assets for Q4 2025 came in at $17.0 billion, up 1.71% year-over-year; the trailing twelve-month figure through Dec 2025 was $17.0 billion (up 1.71% YoY), and the FY2025 annual result was $17.0 billion, up 31454.2% from the prior year.
  • Non-Current Assets was $17.0 billion for Q4 2025 at Grifols, up from $16.8 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $17.0 billion in Q4 2025 and troughed at $15.7 billion in Q4 2021.
  • Average Non-Current Assets over 5 years is $16.5 billion, with a median of $16.8 billion recorded in 2024.
  • Year-over-year, Non-Current Assets increased 8.73% in 2021 and dropped 5.24% in 2023.
  • Over 5 years, Non-Current Assets stood at $15.7 billion in 2021, then advanced by 7.48% to $16.9 billion in 2022, then slipped by 5.24% to $16.0 billion in 2023, then increased by 4.77% to $16.8 billion in 2024, then rose by 1.71% to $17.0 billion in 2025.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $17.0 billion in Q4 2025, $16.8 billion in Q4 2024, and $16.0 billion in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 61.74 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 141.72 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 102.93 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 84.40 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 125.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 61.03 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 37.64 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 165.18 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Grifols - - - 17.04 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 17.04 Bn
Dec 31, 2024 16.75 Bn
Dec 31, 2023 15.99 Bn
Dec 31, 2022 16.87 Bn
Dec 31, 2021 15.70 Bn
Dec 31, 2020 14.44 Bn
Sep 30, 2020 14.02 Bn
Mar 31, 2020 13.50 Bn
Dec 31, 2019 11.27 Bn
Sep 30, 2019 11.55 Bn
Mar 31, 2019 11.25 Bn
Dec 31, 2018 10.27 Bn
Sep 30, 2018 10.18 Bn
Jun 30, 2018 10.13 Bn
Mar 31, 2018 9.72 Bn
Dec 31, 2017 9.39 Bn
Jun 30, 2017 9.09 Bn
Dec 31, 2016 7.57 Bn
Sep 30, 2016 7.38 Bn
Jun 30, 2016 7.48 Bn